Value Bridge — LOMA LINDA UNIVERSITY MEDICAL CENTER
Current $-62M → Target $-35M (+$27.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-62.4M
Current EBITDA
$-34.8M
Target EBITDA
+$27.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$6.2M
Payer Mix Optimization
$15.0M
Cost to Collect Reduction
$5.0M
Clean Claim Improvement
$3.7M
Volume & Rate Growth
$25.0M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-62M to $-35M. The highest-impact lever is Volume & Rate Growth at $10.0M probability-weighted.
IC talking point: "We see $28M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $303M in equity value creation."